• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. LGN POROUS CR FEM SZ 6L; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. LGN POROUS CR FEM SZ 6L; PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO Back to Search Results
Model Number 71423246
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Fungal Infection (2419)
Date of Event 11/21/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that, after a tka surgery performed on (b)(6) 2018, the patient experienced a fungal infection.A revision surgery was performed on (b)(6) 2022 in where a lgn porous cr fem sz 6l, a gns ii resurf pat 35mm, a lgn xlpe dished isrt sz 5-6 11mm and a gns ii cmt tib size 5 {} left were explanted, and a spacer was put in.The current health status of the patient is unknown.
 
Additional Manufacturer Narrative
Internal complaint reference (b)(4).
 
Additional Manufacturer Narrative
H3, h6: the devices were not returned for evaluation; therefore, devices analysis could not be performed.The clinical/medical investigation concluded that, per complaint details, the patient had a fungal infection approximately four years post total knee arthroplasty, that required a revision in which a gn porous cr fem sz 6l, a gns ii resurf pat 35mm, a lgn xlpe dished isrt sz 5-6 11mm and a gns ii cmt tib size 5 {} left were explanted.As of the date of this medical investigation, the requested clinical documentation has not been provided for evaluation.Therefore, there were no clinical factors found which would have contributed to the reported event.The impact to the patient beyond the revision surgery cannot be definitely concluded.No further clinical assessment can be rendered at this time.Should additional clinical documentation become available in the future, the clinical/medical task may be re-evaluated.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part numbers legion porous cruciate retaining femoral size 6 left, legion highly cross linked polyethylene dished insert size 5-6 11mm, genesis ii non-porous tibial baseplate size 5 left over 12 months and for the batch numbers based on historical data of the device did not reveal similar events for the listed device.A review of complaint history revealed similar events for the listed device gns ii resurf pat 35mm over 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for knee systems revealed that acute post-surgical wound infection has been identified in possible adverse effects.Active, local infection or previous intra-articular infections are identified in contraindications for total knee replacement.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.A review of the sterilization records revealed the batches were sterilized within normal parameters.At this time, we have no reason to suspect that the products failed to meet any product specifications at the time of manufacture.With the results of this investigation the root cause of this event could not be determined.A factor that could contribute to the reported event include patient reaction.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LGN POROUS CR FEM SZ 6L
Common Device Name
PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED, POROUS, CO
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key15976128
Report Number1020279-2022-04961
Device Sequence Number14923470
Product Code MBH
UDI-Device Identifier00885556032343
UDI-Public00885556032343
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
K073325
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2022
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number71423246
Device Catalogue Number71423246
Device Lot Number17BHA0015A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/21/2022
Supplement Date Received by Manufacturer02/06/2023
Initial Report FDA Received Date12/14/2022
Supplement Report FDA Received Date02/07/2023
Date Device Manufactured10/26/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71420168 GNS II CMT TIB SIZE 5 {} LEFT; 71420578 GNS II RESURF PAT 35MM; 71453285 LGN XLPE DISHED ISRT SZ 5-6 11MM
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-